logo
Share SHARE
FONT-SIZE Plus   Neg

Zynga Slips To Loss In Q4 - Quick Facts

Zynga Inc. (ZNGA) reported that its fourth-quarter net loss attributable to common stockholders was $435.01 million, compared to net income of $16.06 million in the same quarter last year. On per share basis, net loss for the quarter was $1.22 compared to net income of $0.05 for the fourth quarter of 2010.

The latest quarter results included $510 million of stock-based compensation expense for restricted stock units issued to employees that was previously unrecognized until triggered by initial public offering.

Non-GAAP earnings per share was $0.05 for the fourth quarter of 2011 compared to $0.09 for the fourth quarter of 2010.

Total Revenue was $311.24 million up from $195.76 million in the year ago quarter. Bookings were at a record level of $306.5 million for the fourth quarter of 2011, an increase of 26% compared to the fourth quarter of 2010 and an increase of 7% compared to the third quarter of 2011.

Looking ahead for fiscal 2012, non-GAAP earnings per share is projected to be in the range of $0.24 to $0.28. Bookings are projected to be in the range of $1.35 billion to $1.45 billion.

by RTT Staff Writer

For comments and feedback: editorial@rttnews.com

Business News

Quick Facts

Editors Pick
The Justice Department, in the antitrust trial against the proposed Aetna- Humana Merger, argued that the merger would harm senior citizens who buy private Medicare plans. The U.S. Department of Justice stated that the merger would also harm consumers who buy plans on Affordable Care Act marketplaces, reports said. However, healthcare insurers Aetna And Humana defended their proposed merger.. Telecommunications firm Sprint has extended its Black Friday unlimited data offer for a limited time, the company said in a statement on Monday. When customers switch at least one line to Sprint and sign up for Unlimited Freedom with AutoPay, they get unlimited data, talk and text starting at just $20 per month/line for a family of five until January 31, 2018. Shares of Cerecor Inc. (CERC) plunged over 13% on Monday on disappointing top-line clinical results from its phase II clinical trial of CERC-501 for smoking cessation.
comments powered by Disqus
Follow RTT